Clinical Trials
5 trialsNCT01629615 2020-10-28
A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer
SOLTI Breast Cancer Research Group
Phase 2 Completed
NCT01610284 2020-08-25
BELLE-2
Novartis
Phase 3 Completed
NCT01633060 2019-01-30
BELLE-3
Novartis
Phase 3 Terminated
NCT01790932 2019-01-23
BKM120 For Triple Negative Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01572727 2017-03-09
BELLE-4
Novartis
Phase 2/3 Completed